1,600
Participants
Start Date
October 24, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Saliva based assay: crude RNA extraction
Crude RNA extraction to inactivate the virus and stabilize the RNA for transport at room temperature. Validation of the crude RNA extraction from saliva in combination with NGS diagnostics and LAMP assays and point of care test (POCT) for rapid detection of viral antigens on patients' samples.
Validation of the NGS method
Compare the results obtained with the next-generation sequencing (NGS) method to the nasopharyngeal swabs analysed in a FAMH certified lab.
Validation of the LAMP assays
The RNA will be analyzed onsite using the loop mediated amplification (LAMP) assay.
Validation of the POCT Antigen and Antibody tests
Rapid point of care tests (POCT) detecting viral protein antigens (Ag) and antibodies (Ab) on patients' samples. POCT are often employed in low income countries, but for COVID-19 they are not yet characterized. Their performance is to be characterized that they can be used as a safe guard if the lab diagnostics fail.
RECRUITING
Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft, Liestal
ETH Zurich Department for Biosystems, Science and Engineering
UNKNOWN
Kanton Basel- Landschaft
UNKNOWN
University Hospital, Basel, Switzerland
OTHER